| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |